2,2-bis(bromomethyl)-1,3-propanediol has been researched along with HIV Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fang, B; Jia, Z; Liu, C; Tu, K; Zhang, L; Zhang, M | 1 |
1 other study(ies) available for 2,2-bis(bromomethyl)-1,3-propanediol and HIV Infections
Article | Year |
---|---|
A versatile CRISPR Cas12a-based point-of-care biosensor enabling convenient glucometer readout for ultrasensitive detection of pathogen nucleic acids.
Topics: beta-Fructofuranosidase; Biosensing Techniques; COVID-19; CRISPR-Cas Systems; DNA; DNA Probes; HIV Infections; Humans; Nucleic Acid Amplification Techniques; Nucleic Acids; Point-of-Care Systems; SARS-CoV-2 | 2022 |